Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Neuroblastoma (SH-SY5Y, differentiated 2)
[{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6991/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6991/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6990/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6990/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a698f/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a698f/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a698e/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a698e/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a698d/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a698d/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a698c/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a698c/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a698b/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a698b/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a698a/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a698a/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6989/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6989/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6988/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6988/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6987/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6987/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6986/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6986/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6985/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6985/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6984/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6984/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6983/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6983/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6982/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6982/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6981/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6981/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6980/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6980/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a697f/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a697f/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a697e/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a697e/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a697d/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a697d/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a697c/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a697c/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a697b/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a697b/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a697a/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a697a/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6979/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6979/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6978/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6978/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6977/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6977/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6976/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6976/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6975/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6975/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6974/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6974/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6973/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6973/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6972/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6972/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6971/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6971/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6970/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6970/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a696f/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a696f/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a696e/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a696e/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a696d/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a696d/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a696c/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a696c/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a696b/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a696b/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a696a/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a696a/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6969/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6969/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6968/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6968/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6967/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6967/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6966/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6966/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6965/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6965/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6964/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6964/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6963/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6963/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6962/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6962/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6961/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6961/630635d07c75bb00281a68f9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/630637b67c75bb00281a6960/630635d07c75bb00281a68f9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/630637b67c75bb00281a6960/630635d07c75bb00281a68f9.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
neuroblastoma,SH-sy5y,SK-N-SH,parkinson,neurogenesis,differentiated,differentiation,n type,SH-sy5y
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
